跳到正文
原文
Science Magazine· @ScienceMagazine · X·· 15 天前AI 评分22
AI 导读

一种新型双特异性抗体同时靶向CCR8以清除调节性T细胞,并靶向CD3以激活更广泛的抗肿瘤T细胞大军。该抗体在小鼠中对抗多种肿瘤类型并增强免疫疗法效果,同时在大型动物中表现安全。@ScienceTM https://scim.ag/4dZ2uL2

正文

A new bispecific antibody targets both CCR8 to deplete regulatory T cells and CD3 to revitalize the broader anti-tumor T cell armada. It combated multiple tumor types and potentiated immunotherapy in mice while being safe in large animals. @ScienceTM https://scim.ag/4dZ2uL2

来源:Science Magazine · x.com